cancer-fighting-biotech-immvirx-secures--15m-from-oneventures

Cancer-fighting biotech ImmVirX secures $15m from OneVentures

You can read the full story here.

Join Our Mailing List

Our mission is to improve outcomes for patients with cancers in which immunotherapy treatments have limited effect

About Us
Our Technology
Immvirx logo
A clinical stage company developing novel oncolytic viruses to create powerful new cancer immunotherapy combinations
Twitter Linkedin
Company
© 2020 ImmVirX Pty Ltd • Site by Alex Shafren & Noise